| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.00029 | 1 |